← All Sponsors
SPONSOR

Abdera Therapeutics Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Small-Cell Lung Cancer (SCLC)Large Cell Neuroendocrine Carcinoma of the Lung
NCT06736418 Phase 1
Recruiting

Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy

Small-Cell Lung Cancer (SCLC)
United States View Trial →